Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: Implications for pulmonary arterial hypertension

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Rothman, Richard B ^a   Cadet, Jean L ^a   Dersch, Christina M ^a   McCoy, Michael T ^a   Lehrmann, Elin ^b   Becker, Kevin G ^b   Bader, Michael ^c   Alenina, Natalia ^c   Baumann, Michael H ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HAPLN3 GENE; HAS2 GENE; KNOCKOUT MOUSE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PULMONARY HYPERTENSION; RETLNA GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; DNA MICROARRAY; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG; METABOLISM; MOUSE MUTANT; PATHOLOGY; PROTEIN BINDING;

MUS; MUS MUSCULUS;

ANIMALS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPERTENSION, PULMONARY; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE; UP-REGULATION;

EID: 79953036923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017735     Document Type: Article

References (29)

1. Rothman RB, Baumann MH, (2009) Serotonergic drugs and valvular heart disease. Expert Opin Drug Saf 8: 317-329.
2. Rothman RB, Ayestas MA, Dersch CM, Baumann MH, (1999) Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension Circulation 100: 869-875.
3. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, et al. (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115: 851-862.
4. Guilluy C, Rolli-Derkinderen M, Tharaux PL, Melino G, Pacaud P, et al. (2007) Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282: 2918-2928.
5. Fanburg BL, Lee SL, (2000) A role for the serotonin transporter in hypoxia-induced pulmonary hypertension. J Clin Invest 105: 1521-1523.
6. Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, et al. (2000) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 105: 1555-1562.
7. Lee SL, Wang WW, Fanburg BL, (2001) Dexfenfluramine as a mitogen signal via the formation of superoxide anion. Faseb J 15: 1324-1325.
8. MacLean MR, Herve P, Eddahibi S, Adnot S, (2000) 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 131: 161-168.
9. Zolkowska D, Rothman RB, Baumann MH, (2006) Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. J Pharmacol Exp Ther 318: 604-610.
10. Zolkowska D, Baumann MH, Rothman RB, (2008) Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels. J Pharmacol Exp Ther 324: 791-797.
11. Dempsie Y, Morecroft I, Welsh DJ, MacRitchie NA, Herold N, et al. (2008) Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Circulation 117: 2928-2937.
12. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, et al. (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299: 76.
13. Cote F, Thevenot E, Fligny C, Fromes Y, Darmon M, et al. (2003) Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A 100: 13525-13530.
14. Fligny C, Fromes Y, Bonnin P, Darmon M, Bayard E, et al. (2008) Maternal serotonin influences cardiac function in adult offspring. Faseb J 22: 2340-2349.
15. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, et al. (2006) Platelet-derived serotonin mediates liver regeneration. Science 312: 104-107.
16. Hamidi SA, Prabhakar S, Said SI, (2008) Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion. European Respiratory Journal 31: 135-139.
17. West J, Harral J, Lane K, Deng Y, Ickes B, et al. (2008) Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am J Physiol Lung Cell Mol Physiol 295: L744-755.
18. Papakonstantinou E, Kouri FM, Karakiulakis G, Klagas I, Eickelberg O, (2008) Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension. European Respiratory Journal 32: 1504-1512.
19. Fan C, Su Q, Li Y, Liang L, Angelini DJ, et al. (2009) Hypoxia-induced mitogenic factor/FIZZ1 induces intracellular calcium release through the PLC-IP(3) pathway. Am J Physiol Lung Cell Mol Physiol 297: L263-270.
20. Weir EK, Reeve HL, Huang JM, Michelakis E, Nelson DP, et al. (1996) Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation 94: 2216-2220.
21. Rochefort GY, Lemaire MC, Eder V, Hanton G, Hyvelin JM, et al. (2006) Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension. European Journal of Pharmacology 550: 149-154.
22. Eddahibi S, Raffestin B, Launay JM, Sitbon M, Adnot S, (1998) Effect of Dexfenfluramine Treatment in Rats Exposed to Acute and Chronic Hypoxia. Amer J Respir Crit Care Med 157: 1111-1119.
23. Launay JM, Herve P, Peoc'h K, Tournois C, Callebert J, et al. (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8: 1129-1135.
24. Guignabert C, Izikki M, Tu LI, Li Z, Zadigue P, et al. (2006) Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circulation Research 98: 1323-1330.
25. MacLean MR, Deuchar GA, Hicks MN, Morecroft I, Shen S, et al. (2004) Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 109: 2150-2155.
26. Angelini DJ, Su Q, Yamaji-Kegan K, Fan C, Skinner JT, et al. (2009) Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 296: L582-593.
27. Morecroft I, Loughlin L, Nilsen M, Colston J, Dempsie Y, et al. (2005) Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. J Pharmacol Exp Ther 313: 539-548.
28. Rothman RB, Reid AA, Mahboubi A, Kim C-H, de Costa BR, et al. (1991) Labeling by [3H]1,3-Di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by σ ligands. MolPharmacol 39: 222-232.
29. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, et al. (2007) Evidence based selection of housekeeping genes. PLoS One 2: e898.